Weber, Michael A.
Schmieder, Roland E.
Kandzari, David E.
Townsend, Raymond R.
Mahfoud, Felix
Tsioufis, Konstantinos
Kario, Kazuomi
Pocock, Stuart
Tatakis, Fotis
Ewen, Sebastian
Choi, James W.
East, Cara
Lee, David P.
Ma, Adrian
Cohen, Debbie L.
Wilensky, Robert
Devireddy, Chandan M.
Lea, Janice P.
Schmid, Axel
Fahy, Martin
Böhm, Michael
Funding for this research was provided by:
Medtronic
Article History
Received: 12 May 2022
Accepted: 4 July 2022
First Online: 19 July 2022
Declarations
:
: Prof Weber is a consultant for Medtronic, ReCor, Ablative Solutions, Johnson & Johnson and Urovant. Prof Schmieder reports grants and personal fees from Medtronic, Recor, and Ablative Solutions. Dr. Kandzari reports institutional research/grant support from Biotronik, Boston Scientific, Cardiovascular Systems, Inc., Orbus Neich, Teleflex, Medtronic and Ablative Solutions; and personal consulting honoraria from Ablative Solutions, Cardiovascular Systems, Inc., Magenta Medical, Medtronic, and Terumo. Prof Townsend is a consultant for Medtronic, AXIO and Janssen, and receives royalties from UpToDate. Prof Mahfoud is supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219), and Deutsche Herzstiftung and has received scientific support and speaker honoraria from Astra-Zeneca, Bayer, Boehringer Ingelheim, Medtronic and ReCor Medical. Prof Tsioufis receives payments from Medtronic for work as center PI. Prof Kario receives personal fees from Medtronic during the conduct of the study; grants from Teijin Pharma, Omron Helthcare, FUKUDA DENSHI, Bayer Yakuhin, A & D, Daiichi Sankyo, Mochida Pharmaceutical, EA pharma, Boehringer Ingelheim Japan, Tanabe Mitsubishi Pharma Corporation, Novartis Pharma K.K., Shionogi & Co., Terumo Corporation, MSD K.K., and Sanwa Kagaku Kenkyusho; personal fees from Bristol-Myers Squibb K.K., Takeda Pharmaceutical, Daiichi Sankyo, Omron Healthcare, Bayer Yakuhin, Mochida Pharmaceutical, and Sumitomo Dainippon Pharma outside the submitted work. Dr. Pocock reports personal fees from Medtronic outside the submitted work. Dr. Tatakis has nothing to disclose. Dr. Ewen received speaker's honorarium and/or travel support from Akcea Therapeutics, AstraZeneca, Bayer, Berlin Chemie, Bristol-Myers Squibb—Pfizer, Böhringer Ingelheim, Daiichi Sankyo, Kaneka Pharma, Medtronic, Novartis and Recor. Dr. Choi reports consulting fees from Medtronic outside the submitted work. Dr. East receives research support from Medtronic. Dr. Lee reports consulting fees and research grants from Medtronic and research grants from Ablative Solutions. Dr. Ma has nothing to disclose. Dr. Cohen receives consulting fees from Medtronic, Recor and Metavention. Dr. Wilensky has nothing to disclose. Dr. Devireddy reports personal consulting honoraria from Edwards Lifesciences, Medtronic, ReCor Medical, and Shockwave Medical. Dr. Lea has nothing to disclose. Dr. Schmid has nothing to report. Mr. Fahy is an employee of Medtronic. Prof Böhm is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Medtronic, Novartis, ReCor Medical, Servier, and Vifor during the conduct of the study.